Cargando…

A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates

BACKGROUND: Our progress towards the goal of eliminating racial health disparities requires methods for assessing the existence, magnitude, and statistical significance of health disparities. In comparing disease rates, we must account for the unreliability of rates computed for small minority popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Goovaerts, Pierre, Meliker, Jaymie R, Jacquez, Geoffrey M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950701/
https://www.ncbi.nlm.nih.gov/pubmed/17650305
http://dx.doi.org/10.1186/1476-072X-6-32
_version_ 1782134570308599808
author Goovaerts, Pierre
Meliker, Jaymie R
Jacquez, Geoffrey M
author_facet Goovaerts, Pierre
Meliker, Jaymie R
Jacquez, Geoffrey M
author_sort Goovaerts, Pierre
collection PubMed
description BACKGROUND: Our progress towards the goal of eliminating racial health disparities requires methods for assessing the existence, magnitude, and statistical significance of health disparities. In comparing disease rates, we must account for the unreliability of rates computed for small minority populations and within sparsely populated areas. Furthermore, as the number of geographic units under study increases, we also must account for multiple testing to assure we do not misclassify disparities as present when they actually are not (false positive). To date and to our knowledge, none of the methodologies in current use simultaneously address all of these important needs. And few, if any studies have undertaken a systematic comparison of methods to identify those that are statistically robust and reliable. RESULTS: We introduced six test statistics for quantifying absolute and relative differences between cancer rates measured in distinct groups (i.e. race or ethnicity). These alternative measures were illustrated using age-adjusted prostate and lung cancer mortality rates for white and black males in 688 counties of the Southeastern US (1970–1994). Statistical performance, including power and proportion of false positives, was investigated in simulation studies that mimic different scenarios for the magnitude and frequency of disparities. Two test statistics, which are based on the difference and ratio of rates, consistently outperformed the other measures. Corrections for multiple testing actually increased misclassification compared with the unadjusted tests and are not recommended. One-tailed tests allowed the researcher to consider a priori hypotheses beyond the basic test that the two rates are different. CONCLUSION: The assessment of significant racial disparities across geographic areas is an important tool in guiding cancer control practices, and public health officials must consider the problems of small population size and multiple comparison, and should conduct disparity analyses using both absolute (difference, RD statistic) and relative (ratio, RR statistic) measures. Simple test statistics to assess the significance of rate difference and rate ratio perform well, and their unadjusted p-values provide a realistic assessment of the proportion of type I errors (i.e. disparities wrongly declared significant).
format Text
id pubmed-1950701
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19507012007-08-23 A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates Goovaerts, Pierre Meliker, Jaymie R Jacquez, Geoffrey M Int J Health Geogr Methodology BACKGROUND: Our progress towards the goal of eliminating racial health disparities requires methods for assessing the existence, magnitude, and statistical significance of health disparities. In comparing disease rates, we must account for the unreliability of rates computed for small minority populations and within sparsely populated areas. Furthermore, as the number of geographic units under study increases, we also must account for multiple testing to assure we do not misclassify disparities as present when they actually are not (false positive). To date and to our knowledge, none of the methodologies in current use simultaneously address all of these important needs. And few, if any studies have undertaken a systematic comparison of methods to identify those that are statistically robust and reliable. RESULTS: We introduced six test statistics for quantifying absolute and relative differences between cancer rates measured in distinct groups (i.e. race or ethnicity). These alternative measures were illustrated using age-adjusted prostate and lung cancer mortality rates for white and black males in 688 counties of the Southeastern US (1970–1994). Statistical performance, including power and proportion of false positives, was investigated in simulation studies that mimic different scenarios for the magnitude and frequency of disparities. Two test statistics, which are based on the difference and ratio of rates, consistently outperformed the other measures. Corrections for multiple testing actually increased misclassification compared with the unadjusted tests and are not recommended. One-tailed tests allowed the researcher to consider a priori hypotheses beyond the basic test that the two rates are different. CONCLUSION: The assessment of significant racial disparities across geographic areas is an important tool in guiding cancer control practices, and public health officials must consider the problems of small population size and multiple comparison, and should conduct disparity analyses using both absolute (difference, RD statistic) and relative (ratio, RR statistic) measures. Simple test statistics to assess the significance of rate difference and rate ratio perform well, and their unadjusted p-values provide a realistic assessment of the proportion of type I errors (i.e. disparities wrongly declared significant). BioMed Central 2007-07-24 /pmc/articles/PMC1950701/ /pubmed/17650305 http://dx.doi.org/10.1186/1476-072X-6-32 Text en Copyright © 2007 Goovaerts et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Goovaerts, Pierre
Meliker, Jaymie R
Jacquez, Geoffrey M
A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title_full A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title_fullStr A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title_full_unstemmed A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title_short A comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
title_sort comparative analysis of aspatial statistics for detecting racial disparities in cancer mortality rates
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950701/
https://www.ncbi.nlm.nih.gov/pubmed/17650305
http://dx.doi.org/10.1186/1476-072X-6-32
work_keys_str_mv AT goovaertspierre acomparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates
AT melikerjaymier acomparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates
AT jacquezgeoffreym acomparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates
AT goovaertspierre comparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates
AT melikerjaymier comparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates
AT jacquezgeoffreym comparativeanalysisofaspatialstatisticsfordetectingracialdisparitiesincancermortalityrates